AIA Group Ltd reduced its stake in shares of The Clorox Company (NYSE:CLX – Get Rating) by 38.1% during the 3rd quarter, HoldingsChannel.com reports. The firm owned 1,395 shares of the company's stock after selling 859 shares during the period. AIA Group Ltd's holdings in Clorox were worth $179,000 at the end of the most recent reporting period.
Other large investors also recently modified their holdings of the company. Heritage Financial Services LLC acquired a new stake in shares of Clorox during the 2nd quarter worth $30,000. Curi Wealth Management LLC grew its holdings in shares of Clorox by 64.5% during the 2nd quarter. Curi Wealth Management LLC now owns 227 shares of the company's stock worth $32,000 after purchasing an additional 89 shares in the last quarter. Charter Oak Capital Management LLC acquired a new stake in shares of Clorox during the 2nd quarter worth $36,000. Massmutual Trust Co. FSB ADV grew its holdings in shares of Clorox by 65.8% during the 3rd quarter. Massmutual Trust Co. FSB ADV now owns 252 shares of the company's stock worth $32,000 after purchasing an additional 100 shares in the last quarter. Finally, LS Investment Advisors LLC acquired a new stake in Clorox in the second quarter valued at about $42,000. 79.12% of the stock is owned by institutional investors and hedge funds.
Get Clorox alerts:Clorox Price Performance
Shares of CLX opened at $141.88 on Friday. The company has a market capitalization of $17.51 billion, a price-to-earnings ratio of 43.52, a price-to-earnings-growth ratio of 2.95 and a beta of 0.31. The business has a 50-day moving average of $145.40 and a 200-day moving average of $143.09. The company has a debt-to-equity ratio of 4.99, a current ratio of 0.88 and a quick ratio of 0.50. The Clorox Company has a 1 year low of $120.50 and a 1 year high of $169.16.
Clorox (NYSE:CLX – Get Rating) last issued its earnings results on Tuesday, November 1st. The company reported $0.93 earnings per share for the quarter, topping analysts' consensus estimates of $0.73 by $0.20. The business had revenue of $1.74 billion during the quarter, compared to the consensus estimate of $1.69 billion. Clorox had a return on equity of 83.00% and a net margin of 5.75%. As a group, equities research analysts anticipate that The Clorox Company will post 4.12 earnings per share for the current year.Clorox Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Friday, February 10th. Shareholders of record on Wednesday, January 25th will be issued a $1.18 dividend. The ex-dividend date of this dividend is Tuesday, January 24th. This represents a $4.72 dividend on an annualized basis and a yield of 3.33%. Clorox's payout ratio is currently 144.79%.
Wall Street Analyst Weigh In
CLX has been the topic of several research analyst reports. DA Davidson raised their price objective on Clorox from $124.00 to $155.00 and gave the company a "neutral" rating in a research note on Wednesday, November 2nd. JPMorgan Chase & Co. raised their price objective on Clorox from $126.00 to $135.00 and gave the company an "underweight" rating in a research note on Friday, January 13th. Evercore ISI initiated coverage on Clorox in a research note on Monday, October 17th. They issued an "underperform" rating on the stock. UBS Group increased their target price on Clorox from $119.00 to $129.00 and gave the company a "sell" rating in a research report on Wednesday, November 2nd. Finally, Morgan Stanley increased their target price on Clorox from $130.00 to $142.00 and gave the company an "equal weight" rating in a research report on Wednesday, November 2nd. Nine equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and one has issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Reduce" and a consensus price target of $136.92.
Clorox Profile
(Get Rating)
The Clorox Co engages in the manufacture and marketing of consumer and professional products. It operates through the following business segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment consists of cleaning products, professional products and vitamins, minerals and supplements mainly marketed and sold in the United States.
Featured Articles
- Get a free copy of the StockNews.com research report on Clorox (CLX)
- EVs, Robotics Among Growth Drivers As Chipmaker STMicro Gaps Up
- Does Oil Services Firm NOV Have Enough Energy To Maintain Rally?
- Shopify Clears Cup-With-Handle Base: Can Momentum Continue?
- The Future Of E-Commerce: Analysis And New Data
- Chevron Delights Shareholders with $75 Billion in Share Buybacks
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Get Rating).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.